Skip to main content
Pangen Biotech Inc. logo

Pangen Biotech Inc. — Investor Relations & Filings

Ticker · 222110 ISIN · KR7222110009 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2022-06-21 Major Shareholding Noti…
Country KR South Korea
Listing KO 222110

About Pangen Biotech Inc.

https://pangen.com/layout/eng/home.php

Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.

Recent filings

Filing Released Lang Actions
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (Pangen) regarding a 'Pledge of Shares' (stock collateral agreement) by the major shareholder. This type of disclosure, involving changes to collateral terms and debt amounts, falls under general regulatory announcements for corporate events that do not fit into specific categories like M&A or Earnings. In the absence of a specific 'Pledge of Shares' category, it is classified as a Regulatory Filing (RNS).
2022-06-21 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Pledge of Shares' (stock collateral agreement) involving a change in the major shareholder's status. This type of disclosure, which details financial arrangements, collateral, and debt obligations of major shareholders, is classified as a 'Capital/Financing Update' (CAP) in our taxonomy, as it pertains to the company's capital structure and financing activities.
2022-05-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (the 'Report on Large Shareholding' or '5% Rule' filing). This falls under the category of Major Shareholding Notification.
2022-05-23 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'PanGen' (주)팬젠, covering the period from 2022.01.01 to 2022.03.31. It contains detailed financial data, business operations, management discussions, and capital structure information. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year that contains actual financial statements or substantive financial data is classified as an Interim / Quarterly Report (IR). Q1 2022
2022-05-13 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed, including financial statement approval, director and auditor appointments, and remuneration limits. This document is an official record of the voting outcomes from the company's Annual General Meeting, which directly aligns with the definition for 'Declaration of Voting Results & Voting Rights Announcements'.
2022-03-24 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for PanGen Co., Ltd. for the fiscal year ending December 31, 2021. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It is not an announcement of a report (RPA) but the full audit report itself, which falls under the 'Audit Report / Information' category. FY 2021
2022-03-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.